COG 150326_Catenion_0233

“I help R&D teams deliver on the promise of gene therapy”

Graham Scholefield

“Sitting at the boundary between science and business is an incredibly rewarding experience”

Webpage Slider Arno Heuermann

“Translating new technologies into viable business ideas”

Arno Heuermann COO, Partner, Managing Director
Webpage Slider Sarah Oelsner

“From bench to bedside and beyond: Translating inspiring science into innovative business strategies is a fascinating journey”

Christian Elze

“China’s policy makers are making a concerted long-term effort to build a competitive biomedical innovation system – but R&D-based value creation
is only just beginning.”

Christian Elze Senior Partner
Webpage Slider Anela Vukoja

„How can patients and the legislature steer the biopharmaceutical industry towards sustainable innovation?“

Dr. Anela Vukoja Associate
DLI 150326_Catenion_8264

“We help our clients to achieve best practise in managing R&D performance”

Markus Thunecke

“Is biopharma ready to embrace the new biology?”

Dr. Markus Thunecke Senior Partner
Webpage Slider Jonathan Vonnemann

“Uncovering the real value of technologies for our clients by seeing through the smoke and mirrors of the industry is just one of the fascinating aspects of working at Catenion”

Sophie von Dyrander

“My decision to join Catenion? Here I found what I was looking for – high level strategy work, international clients and the team spirit of a smaller firm.”

Webpage Slider Pascal Joly

“At Catenion, I can put my scientific background in cell therapy and regenerative medicine to practical use and help bring innovative therapies to the market.“

Pascal Joly Analyst
Matthias Krings

“Change-Management is a team effort – let’s get started”

Dr. Matthias Krings Senior Partner


Focus on 2017

Medicine Maker, January 2017 - It seems likely that 2016 will go down as one of the most eventful years in modern history, but what did the pharma industry make of it? Here, we quiz a number of past contributors to The Medicine Maker for their opinions on 2016 – and ask them what priorities [...]
Download this article

Biopharma R&D Productivity and Growth 2016: Innovation Performance Improves

In Vivo, January  2016  -  Catenion updates its annual list of the year’s top pharma R&D performers, based on R&D productivity and growth. This year Regeneron shoots to the top and Gilead drops to third place.
Download this article

Meet Us

April 11, 2017

CANCER ADVANCE, Harvard Medical School, Boston

March 7, 2017

European Parliament, Can Real World Data Advance Equity of Health Care in Europe? Brussels

2. - 3. March 2017

Pharmaceutical PPM Toolbox, London

Feb 1st, 2017

Tokyo University – Cultural Challenges in Translational Research